Orchid Pharma Limited (NSE:ORCHPHARMA)
India
· Delayed Price · Currency is INR 840.95
+32.40 (4.01%)
Apr 28, 2025, 2:30 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 41.01 billion as of April 25, 2025. Its market cap has decreased by -28.45% in one year.
Market Cap
41.01B
Enterprise Value
40.22B
Revenue
9.02B
Ranking
n/a
PE Ratio
36.98
Stock Price
840.95
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 41.01B, an increase of 5,538.14%. That is a compound annual growth rate of 146.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 41.01B | -55.26% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | 4.98B | 584.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,288.57B |
| Divi's Laboratories | 1,596.13B |
| Cipla | 1,232.34B |
| Mankind Pharma | 1,055.17B |
| Apollo Hospitals Enterprise | 999.73B |
| Zydus Lifesciences | 865.01B |
| Aurobindo Pharma | 708.64B |
| Alkem Laboratories | 601.83B |